Report Detail

Medical Devices & Consumables Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019

  • RnM3864496
  • |
  • 10 January, 2020
  • |
  • Global
  • |
  • 472 Pages
  • |
  • GlobalData
  • |
  • Medical Devices & Consumables

Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiovascular Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date


Table of Contents

  • 1.1 List of Tables 13
  • 1.2 List of Figures 22

2 Introduction 23

  • 2.1 Cardiovascular Surgery Devices Overview 23

3 Products under Development 24

  • 3.1 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 24
  • 3.2 Cardiovascular Surgery Devices - Pipeline Products by Segment 25
  • 3.3 Cardiovascular Surgery Devices - Pipeline Products by Territory 26
  • 3.4 Cardiovascular Surgery Devices - Pipeline Products by Regulatory Path 27
  • 3.5 Cardiovascular Surgery Devices - Pipeline Products by Estimated Approval Date 28
  • 3.6 Cardiovascular Surgery Devices - Ongoing Clinical Trials 29

4 Cardiovascular Surgery Devices - Pipeline Products under Development by Companies 30

  • 4.1 Cardiovascular Surgery Devices Companies - Pipeline Products by Stage of Development 30
  • 4.2 Cardiovascular Surgery Devices - Pipeline Products by Stage of Development 35

5 Cardiovascular Surgery Devices Companies and Product Overview 40

  • 5.1 3DT Holdings LLC Company Overview 40
    • 5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.2 AblaCor Medical Corporation Company Overview 41
    • 5.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.3 Adagio Medical Inc. Company Overview 43
    • 5.3.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.4 Advanced Catheter Therapies Inc Company Overview 46
    • 5.4.1 Advanced Catheter Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.5 AdvanSource Biomaterials Corporation Company Overview 48
    • 5.5.1 AdvanSource Biomaterials Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.6 AFreeze GmbH Company Overview 49
    • 5.6.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.7 AngioDynamics Inc Company Overview 53
    • 5.7.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.8 Apaxis Medical Inc Company Overview 56
    • 5.8.1 Apaxis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.9 APK Advanced Medical Technologies, Inc. Company Overview 59
    • 5.9.1 APK Advanced Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.10 Applied Medical Resources Corporation Company Overview 60
    • 5.10.1 Applied Medical Resources Corporation Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.11 Atrian Medical Ltd Company Overview 61
    • 5.11.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.12 AtriCure Inc Company Overview 62
    • 5.12.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • 5.13 Axcelon Biopolymers Corp. Company Overview 69
    • 5.13.1 Axcelon Biopolymers Corp. Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.14 Baylis Medical Company Inc Company Overview 70
    • 5.14.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.15 Beth Israel Deaconess Medical Center Inc Company Overview 72
    • 5.15.1 Beth Israel Deaconess Medical Center Inc Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.16 Bioretec Ltd Company Overview 74
    • 5.16.1 Bioretec Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
  • 5.17 Boston University Company Overview 75
    • 5.17.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.18 Breethe, Inc. Company Overview 76
    • 5.18.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.19 CardiacAssist Inc Company Overview 77
    • 5.19.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.20 CardioPolymers Inc Company Overview 78
    • 5.20.1 CardioPolymers Inc Pipeline Products & Ongoing Clinical Trials Overview 78

6 Cardiovascular Surgery Devices- Recent Developments 228

  • 6.1 Nov 26, 2019: MiMedx announces Securities and Exchange Commission Settlement 228
  • 6.2 Nov 26, 2019: MiMedx names William "Butch" Hulse as General Counsel and Secretary 228
  • 6.3 Nov 26, 2019: SEC charges biotech company and executives with accounting fraud 229
  • 6.4 Nov 20, 2019: First cryoballoon ablation procedures performed using the VersaCross Transseptal Solution 230
  • 6.5 Nov 19, 2019: Hancock Jaffe Medical Team to make presentations at 46th Annual VEITH Vascular Symposium 230

7 Appendix 469

  • 7.1 Methodology 469
  • 7.2 About GlobalData 472
  • 7.3 Contact Us 472

Summary:
Get latest Market Research Reports on Cardiovascular Surgery Devices. Industry analysis & Market Report on Cardiovascular Surgery Devices is a syndicated market report, published as Cardiovascular Surgery Devices - Medical Devices Pipeline Assessment, 2019. It is complete Research Study and Industry Analysis of Cardiovascular Surgery Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$4,000.00
$8,000.00
$12,000.00
3,188.00
6,376.00
9,564.00
3,716.00
7,432.00
11,148.00
611,720.00
1,223,440.00
1,835,160.00
333,680.00
667,360.00
1,001,040.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report